These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1824978)

  • 1. Cytokine-induced delivery of the costimulatory signal for a v-mos-transfected nonallostimulating, MHC I+II+ clone of the murine macrophage cell line P388D1 and induction of tolerance.
    Müller-Ruchholtz W; Seliger B; Eckstein V; Wottge HU
    Transplant Proc; 1991 Feb; 23(1 Pt 1):226-8. PubMed ID: 1824978
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological properties of the murine macrophage cell line P388D1 and its oncogene transfectants in the induction of alloresponses.
    Wottge HU; Seliger B; Müller-Ruchholtz W
    Transplant Proc; 1990 Aug; 22(4):1994. PubMed ID: 2143870
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of oncogenes and cell metabolism on immunogenicity and tolerogenicity of a model macrophage cell line.
    Wottge HU; Seliger B; Eckstein V; Müller-Ruchholtz W
    Transplant Proc; 1993 Feb; 25(1 Pt 1):152-3. PubMed ID: 8438258
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphokine-independent induction of macrophage membrane IL-1 by autoreactive T cells recognizing either class I or class II MHC determinants.
    Wasik MA; Donnelly RP; Beller DI
    J Immunol; 1988 Nov; 141(10):3456-62. PubMed ID: 2460535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus.
    Blasi E; Radzioch D; Merletti L; Varesio L
    Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of antigen specificity, class II major histocompatibility complex restriction, and in vivo behavior of myelin basic protein-specific T cell lines and clones derived from (BALB/c x SJL/J) mice.
    Trotter J; Zamvil SS; Steinman L
    J Immunol; 1987 Sep; 139(6):1834-9. PubMed ID: 2442257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Memory T cells generated in vitro to class I+, II- hepatocytes.
    Bumgardner GL; Almond PS; Chen S; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):104-5. PubMed ID: 1990489
    [No Abstract]   [Full Text] [Related]  

  • 11. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.
    Chen PW; Ananthaswamy HN
    J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types.
    Marrack P; Kappler J
    Nature; 1988 Apr; 332(6167):840-3. PubMed ID: 3258650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
    Gur H; Geppert TD; Wacholtz MC; Lipsky PE
    Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the immune response T-cell interactions.
    Dutton RW; Swain SL
    CRC Crit Rev Immunol; 1982 Feb; 3(3):209-61. PubMed ID: 6176399
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL; Lake RA; Robinson BW; Scott B
    Cancer Res; 1999 Mar; 59(5):1071-9. PubMed ID: 10070965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell tolerance by clonal anergy in transgenic mice with nonlymphoid expression of MHC class II I-E.
    Burkly LC; Lo D; Kanagawa O; Brinster RL; Flavell RA
    Nature; 1989 Nov; 342(6249):564-6. PubMed ID: 2531293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between lymphocyte-induced donor-specific tolerance and donor cell recirculation. Role of class I and class II major histocompatibility complex.
    Sheng-Tanner XF; Miller RG
    Transplantation; 1994 Apr; 57(7):1081-7. PubMed ID: 8165707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.
    Wong GH; Clark-Lewis I; McKimm-Breschkin L; Harris AW; Schrader JW
    J Immunol; 1983 Aug; 131(2):788-93. PubMed ID: 6408189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The syngeneic mixed leukocyte reaction in mice. II. The I region control of suppressor T cell activity induced in the syngeneic mixed leukocyte reaction.
    Yamashita U; Ono S; Nakamura H
    J Immunol; 1982 Mar; 128(3):1010-7. PubMed ID: 6460057
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone marrow-derived macrophage expression of endogenous and transfected class II MHC genes during differentiation in vitro.
    Pullen JK; Schook LB
    J Immunol; 1986 Aug; 137(4):1359-65. PubMed ID: 3090147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.